RANDOM PROSPECTIVE-STUDY OF VINDESINE VERSUS VINDESINE PLUS HIGH-DOSE CISPLATIN VERSUS VINDESINE PLUS CISPLATIN PLUS MITOMYCIN-C IN ADVANCED NON-SMALL-CELL LUNG-CANCER

被引：134
|
作者：
EINHORN, LH
LOEHRER, PJ
WILLIAMS, SD
MEYERS, S
GABRYS, T
NATTAN, SR
WOODBURN, R
DRASGA, R
SONGER, J
FISHER, W
STEPHENS, D
HUI, S
机构：
[1] INDIANA UNIV,SCH MED,DEPT MED,DIV HEMATOL ONCOL,INDIANAPOLIS,IN 46202
[2] PARKVIEW MEM HOSP,FT WAYNE,IN
[3] BULL MEM HOSP,MUNCIE,IN
[4] INDIANA UNIV,DEPT MED,BIOSTAT SECT,INDIANAPOLIS,IN 46204
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 07期
关键词：
D O I：
10.1200/JCO.1986.4.7.1037
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1037 / 1043
页数：7
相关论文
共 50 条
  • [31] A PHASE-II STUDY OF VINDESINE PLUS ETOPOSIDE IN METASTATIC NON-SMALL-CELL LUNG-CANCER
    HUPPERETS, PSGJ
    TENVELDE, GPM
    BRON, H
    SCHOUTEN, L
    BLIJHAM, GH
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (05) : 674 - 675
  • [32] A RANDOMIZED PROSPECTIVE-STUDY OF CISPLATIN AND VINBLASTINE VERSUS CISPLATIN, VINBLASTINE AND MITOMYCIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    MYLONAKIS, N
    TSAVARIS, N
    BACOYIANNIS, C
    KARVOUNIS, N
    KAKOLYRIS, S
    KARABELIS, A
    BEER, M
    KOSMIDIS, P
    ANNALS OF ONCOLOGY, 1992, 3 (02) : 127 - 130
  • [33] CHEMOTHERAPY OF NON-SMALL CELL LUNG-CANCER WITH CISPLATIN AND VINDESINE
    DRINGS, P
    KLECKOW, M
    MANKE, HG
    STIEFEL, E
    ONKOLOGIE, 1984, 7 (04): : 202 - 204
  • [34] CISPLATIN AND VINDESINE FOR DISSEMINATED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE TRIAL WITH 81 PATIENTS
    TOURANI, JM
    PENAUD, D
    CAUBARRERE, I
    DARSE, J
    BALZON, JC
    BOITA, F
    LEBAS, FX
    LAFITTE, JJ
    ANDRIEU, JM
    BULLETIN DU CANCER, 1990, 77 (11) : 1107 - 1113
  • [35] COMBINATION CHEMOTHERAPY WITH MITOMYCIN-C, VINDESINE, AND IFOSFAMIDE IN THE TREATMENT OF INOPERABLE NON-SMALL-CELL LUNG-CANCER
    GATZEMEIER, U
    HOSSFELD, DK
    RADENBACH, D
    ZSCHABER, R
    ONKOLOGIE, 1985, 8 (04): : 208 - 212
  • [36] PROSPECTIVE RANDOMIZED STUDY WITH CROSSOVER IN METASTATIC BREAST-CANCER - MITOXANTRONE PLUS VINDESINE VERSUS 4'-EPIDOXORUBICIN PLUS VINDESINE AND MITOXANTRONE PLUS PREDNIMUSTINE VERSUS 4'-EPIDOXORUBICIN PLUS PREDNIMUSTINE
    LEHNERT, M
    HAUSMANINGER, H
    LENZHOFER, R
    ONKOLOGIE, 1987, 10 (05): : 276 - 277
  • [37] Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer
    Perol, M
    Guerin, JC
    Thomas, P
    Poirier, R
    Carles, P
    Robinet, G
    Kleisbauer, JP
    Paillotin, D
    Vergnenegre, A
    Balmes, P
    Touron, D
    Grivaux, M
    Pham, E
    LUNG CANCER, 1996, 14 (01) : 119 - 134
  • [38] ETOPOSIDE VERSUS ETOPOSIDE PLUS HIGH-DOSE CISPLATIN IN THE MANAGEMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE RANDOMIZED FONICAP TRIAL
    ROSSO, R
    SALVATI, F
    ARDIZZONI, A
    CURCIO, CG
    RUBAGOTTI, A
    BELLI, M
    CASTAGNETO, B
    FUSCO, V
    SASSI, M
    FERRARA, G
    PIZZA, A
    PEDICINI, T
    SORESI, E
    SCODITTI, S
    CIOFFI, R
    FOLCO, U
    MONACO, M
    MERLANO, M
    RIMOLDI, R
    TONACHELLA, R
    CRUCIANI, A
    COLANTUONI, G
    RINALDI, M
    PORTALONE, L
    BRUZZI, P
    SANTI, L
    CANCER, 1990, 66 (01) : 130 - 134
  • [39] RANDOMIZED STUDY OF VINORELBINE AND CISPLATIN VERSUS VINDESINE AND CISPLATIN VERSUS VINORELBINE ALONE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - RESULTS OF A EUROPEAN MULTICENTER TRIAL INCLUDING 612 PATIENTS
    LECHEVALIER, T
    BRISGAND, D
    DOUILLARD, JY
    PUJOL, JL
    ALBEROLA, V
    MONNIER, A
    RIVIERE, A
    LIANES, P
    CHOMY, P
    CIGOLARI, S
    GOTTFRIED, M
    RUFFIE, P
    PANIZO, A
    GASPARD, MH
    RAVAIOLI, A
    BESENVAL, M
    BESSEN, F
    MARTINEZ, A
    BERTHAUD, P
    TURSZ, T
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) : 360 - 367
  • [40] CARBOPLATIN AND VINDESINE IN ADVANCED NON-SMALL-CELL LUNG-CANCER - A FEASIBILITY STUDY
    TUCCI, E
    ALGERI, R
    TRUSSO, M
    PEPI, F
    SCHIAROLI, G
    JOURNAL OF CHEMOTHERAPY, 1992, 4 (02) : 119 - 122
12345